Biopharmaceutical Research Co — Form D/A
Biopharmaceutical Research Co of CASTROVILLE, CA, a company, filed a Form D amendment with the SEC on 2023-06-20. The offering totals $23.2M, of which $23.2M was reported sold. Industry: Other Technology.
Offering
- Filed: 2023-06-20
- Form: D/A
- Accession: 0001826834-23-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $23.2M
- Amount sold: $23.2M
- Investors: 36
- Date of first sale: 2022-07-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-452292
Issuer
- Name: Biopharmaceutical Research Co
- CIK: 0001826834
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 11045 COMMERCIAL PARKWAY, CASTROVILLE, CA, 95012
- Phone: 831-632-0913
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Edward Howard Goodwin | Director | Castroville, CA |
| Charles Bennett Schumacher | Director | Castroville, CA |
| David Bennett Weinmann | Executive Officer | Castroville, CA |
| George Bennett Hodgin | Director | Castroville, CA |
| George Bennett Hodgin | Executive Officer | Castroville, CA |
| Osagie Bennett Imasogie | Director | Castroville, CA |
| Charles Schumacher | Director | Castroville, CA |
| George Hodgin | Director | Castroville, CA |
| George Hodgin | Executive Officer | Castroville, CA |
Other filings by this issuer (6)
More